99 related articles for article (PubMed ID: 15817340)
1. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer.
Díaz-González JA; Calvo FA; Cortés J; de La Mata D; Gómez-Espí M; Lozano MA; Lozano E; Serrano J; Herranz R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1378-84. PubMed ID: 15817340
[TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
3. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
8. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.
Fernández-Martos C; Aparicio J; Bosch C; Torregrosa M; Campos JM; Garcera S; Vicent JM; Maestu I; Climent MA; Mengual JL; Tormo A; Hernandez A; Estevan R; Richart JM; Viciano V; Uribe N; Campos J; Puchades R; Arlandis F; Almenar D
J Clin Oncol; 2004 Aug; 22(15):3016-22. PubMed ID: 15210740
[TBL] [Abstract][Full Text] [Related]
9. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
Pfeiffer P
Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study.
Gambacorta MA; Valentini V; Morganti AG; Mantini G; Miccichè F; Ratto C; Di Miceli D; Rotondi F; Alfieri S; Doglietto GB; Vargas JG; De Paoli A; Rossi C; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):130-8. PubMed ID: 15337548
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
12. [Our experiences of preoperative chemo-radiotherapy for T4 primary rectal cancer].
Sato H; Maeda K; Hanai T; Koide Y; Aoyama H; Matsuoka H; Katsuno H; Funahashi M; Agata T; Noro T; Honda K; Shiota M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2018-20. PubMed ID: 19106509
[TBL] [Abstract][Full Text] [Related]
13. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA; Valentini V; Coco C; Morganti AG; Smaniotto D; Miccichè F; Mantini G; Barbaro B; Garcia-Vargas JE; Magistrelli P; Picciocchi A; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):139-48. PubMed ID: 15337549
[TBL] [Abstract][Full Text] [Related]
16. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
Katz MS; Minsky BD; Saltz LB; Riedel E; Chessin DB; Guillem JG
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1363-70. PubMed ID: 16029794
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I
ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
Wang LW; Yang SH; Lin JK; Lin TC; Chan WK; Chen WS; Wang HS; Jiang JK; Lee RC; Li AF; Chao Y; Chi KH; Yen SH
J Surg Oncol; 2005 Mar; 89(4):256-63; discussion 263-4. PubMed ID: 15726610
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer.
Roeder F; Treiber M; Oertel S; Dinkel J; Timke C; Funk A; Garcia-Huttenlocher H; Bischof M; Weitz J; Harms W; Hensley FW; Buchler MW; Debus J; Krempien R
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1381-8. PubMed ID: 17275208
[TBL] [Abstract][Full Text] [Related]
20. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
